Schedule 13G ownership disclosure

Allena Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 018119107

Event date: 2019-06-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,340,136
Percent of class
9.9800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-19-004763
Form type
SC 13G
Filer
Allena Pharmaceuticals, Inc.
CIK
CIK 1624658
Filed
Jul 02, 2019
Reporting period
Jun 28, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub